Millennium Management’s Checkmate Pharmaceuticals, Inc. Common Stock CMPI Stock Holding History

Millennium Management’s Portfolio CMPI Stock Details CMPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,633	Closed	-$31K	–	8015
2021 Q4	$31K	Buy	+10,633	New	+$39.6K	﹤0.01%	6566
2021 Q3	–	Sell	-40,422	Closed	-$241K	–	7517
2021 Q2	$241K	Buy	+40,422	New	+$286K	﹤0.01%	5900
2021 Q1	–	Sell	-60,695	Closed	-$886K	–	6708
2020 Q4	$886K	Sell	60,695 -48,374	-44%	-$616K	﹤0.01%	3814
2020 Q3	$1.25K	Buy	+109,069	New	+$1.4M	﹤0.01%	2970

Other funds holding CMPI

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Millennium Management's CMPI Position: Q1 2022 in Review

Millennium Management sold out of Checkmate Pharmaceuticals, Inc. Common Stock (CMPI) in Q1 2022, closing a stake of 10,633 shares — an estimated $31K sold.

Millennium Management first reported a position in CMPI in Q3 2020 and held it in 4 quarters. The position peaked at $886K in Q4 2020. 26 funds tracked by Wall St. Rank hold CMPI as of Q1 2022.

Millennium Management reported no remaining Checkmate Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Millennium Management sold 10,633 Checkmate Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $31K.
Millennium Management first reported a position in Checkmate Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
Millennium Management's Checkmate Pharmaceuticals, Inc. Common Stock position peaked at $886K in Q4 2020.
26 funds tracked by Wall St. Rank held Checkmate Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Millennium Management's 13F filing for Q1 2022, filed 16 May 2022.